Sonoma Pharmaceuticals
SNOA
19 hedge funds and large institutions have $2.35M invested in Sonoma Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
36% more funds holding
Funds holding: 14 → 19 (+5)
25% more capital invested
Capital invested by funds: $1.88M → $2.35M (+$474K)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$197K |
| 2 |
OC
Oppenheimer & Co
New York
|
+$117K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$39.9K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$34.6K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$5.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$157K |
| 2 |
Morgan Stanley
New York
|
-$87.7K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$69.1K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$53.2K |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$50K |
SNOA Hedge Fund Activity: Q4 2013 in Review
19 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2013, worth a combined $2.35M — up 25% from $1.88M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SNOA positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $197K. The largest seller was BlackRock Institutional Trust, cutting an estimated $157K.
- 19 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2013, up from 14 in Q3 2013.
- Funds reported $2.35M of Sonoma Pharmaceuticals stock for Q4 2013, up 25% quarter-over-quarter.
- 6 funds opened new Sonoma Pharmaceuticals positions in Q4 2013 and 1 closed out, a net change of +5 holders.
- The largest Sonoma Pharmaceuticals buyer in Q4 2013 was Vanguard Group, an estimated $197K added.
- The largest Sonoma Pharmaceuticals seller in Q4 2013 was BlackRock Institutional Trust, an estimated $157K sold.
Based on aggregated 13F filings for Q4 2013.